Skip to main content
Fig. 1 (abstract O-009). | BMC Proceedings

Fig. 1 (abstract O-009).

From: Abstracts from the 26th European Society for Animal Cell Technology Meeting - Cell culture technologies: bridging academia and industry to provide solutions for patients

Fig. 1 (abstract O-009).

A multifaceted approach to accelerate cell line development whilst maintaining quality. (A) Protein A HPLC quantified day 14 fed-batch titres for recombinant cell lines derived from Apollo™ (limiting dilution cloning) and Apollo™ X (Chemostat) host cell lines. Four mAbs were expressed in each cell line. (B) Timeline showing transfection to research cell bank in 10 weeks, (C) Protein A HPLC quantified day 14 fed-batch titres for six recombinant DG44 cell lines expressing the same mAb

Back to article page

BMC Proceedings

ISSN: 1753-6561

Contact us